Drugs / SB2
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01936181 | Aug 2013 → Sep 2014 | rheumatoid arthritis | Samsung Bioepis Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SB2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01936181 ↗ |
| Route | Intravenous | “via intravenous infusion” NCT01936181 ↗ |